The drugmaker’s gene therapy unit Avexis said new data showed positive results of its Zolgensma drug for a broad spectrum of spinal muscular atrophy patients. The company is confident it will …
Swiss stocks – Factors to watch on May 6
Swiss stocks – Factors to watch on May 6
Leave a reply